KYMR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Kymera Therapeutics (KYMR) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

KYMR is expected to report earnings to fall 6.26% to -76 cents per share on February 20

Kymera Therapeutics KYMR Stock Earnings Reports

Q4'24

Est.

$-0.77

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.10

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.15

The last earnings report on October 31 showed earnings per share of -81 cents, beating the estimate of -82 cents. With 131.13K shares outstanding, the current market capitalization sits at 3.15B.

View a ticker or compare two or three

Compare

KYMR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For KYMR
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for KYMR (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

200 Arsenal Yards Boulevard

Phone

+1 857 285-5300

Employees

187

Web

https://www.kymeratx.com